FIELD: medicine. SUBSTANCE: method involves making use of normal cell membrane fragments procoagulation activity level reduction property in patients having lupus erythematosus anticoagulant in plasma. Donor cell membrane fragments are to be added to blood plasma under study with phospholipid cell membrane fragments being removed from the plasma. Kaolin coagulation time is measured. R2 index is calculated as ratio between the kaolin coagulation time in plasma with phospholipid cell membrane fragments being removed and the kaolin coagulation time in plasma with donor phospholipid cell membrane fragments added. R2 value being less than 1.5, lupus erythematosus anticoagulant availability is considered to be determined. EFFECT: improved specificity of test; simplified and accelerated test method. 4 dwg, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DIAGNOSING ANTIPHOSPHOLIPID SYNDROME | 1995 |
|
RU2104550C1 |
METHOD OF DETERMINING THROMBOPHILIA CAUSED BY RESISTANCE OF V FACTOR TO ACTIVATED PROTEIN C | 1996 |
|
RU2129282C1 |
METHOD OF DIAGNOSIS OF THROMBOPHILIA DETERMINED BY RESISTANCE OF FACTOR V TO ACTIVATED PROTEIN C | 2001 |
|
RU2205411C2 |
METHOD FOR CONTROL OF SUBSTITUTIONAL THERAPY EFFICIENCY AT DVS- SYNDROME | 2000 |
|
RU2190855C2 |
METHOD FOR DETECTING LUPUS ANTICOAGULANT | 2003 |
|
RU2239197C1 |
METHOD FOR PREDICTING ANTIPHOSPHOLIPID SYNDROME | 2003 |
|
RU2254572C2 |
METHOD FOR DIAGNOSING ANTIPHOSPHOLIPID SYNDROME | 2000 |
|
RU2186391C2 |
HEPARIN CONCENTRATION DETERMINATION METHOD | 2003 |
|
RU2249819C2 |
METHOD FOR PREDICTING THE COURSE OF PYOTHORAX AND PNEUMONIC EMPYEMA | 1992 |
|
RU2043636C1 |
METHOD FOR DIAGNOSIS OF ANTIPHOSPHOLIPID SYNDROME IN PATIENTS WITH THROMBOSIS AND/OR OBSTETRIC PATHOLOGY | 2022 |
|
RU2804231C1 |
Authors
Dates
2002-04-10—Published
1999-03-23—Filed